Theralase Technologies Inc. Stock
Stocks
TLT
CA88337V1004
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Toronto S.E.
23:51:21 20/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.1750 CAD | -5.41% |
|
-5.41% | +6.06% |
| 10-26 | Theralase® Technologies Inc. Provides Bladder Cancer Clinical Study Update and Oncology Pipeline Expansion | CI |
| 09-15 | Theralase Technologies Commences GLP Toxicology Analysis of Rutherrin | CI |
| Market Cap | 57.44M 40.11M 36.53M 33.66M 30.62M 3.71B 60.37M 410M 163M 2.03B 150M 147M 6.37B | P/E 2026 * |
-18.5x | P/E 2027 * | 9.25x |
|---|---|---|---|---|---|
| Enterprise Value | 57.44M 40.11M 36.53M 33.66M 30.62M 3.71B 60.37M 410M 163M 2.03B 150M 147M 6.37B | EV / Sales 2026 * |
73.1x | EV / Sales 2027 * | 1.69x |
| Free-Float |
79.6% | Yield 2026 * |
-
| Yield 2027 * | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| TLT | Delayed | |
| TLTFF | Delayed | ||
| TTX | Delayed | ||
| TTX | Delayed |
Last Transcript: Theralase Technologies Inc.
| 1 day | -5.41% | ||
| 1 week | -5.41% | ||
| Current month | -2.78% | ||
| 1 month | -5.41% | ||
| 3 months | -7.89% | ||
| 6 months | -27.08% | ||
| Current year | +6.06% |
| 1 week | 0.17 | 0.19 | |
| 1 month | 0.17 | 0.25 | |
| Current year | 0.16 | 0.41 | |
| 1 year | 0.14 | 0.41 | |
| 3 years | 0.14 | 0.41 | |
| 5 years | 0.14 | 0.48 | |
| 10 years | 0.12 | 0.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 29/06/2023 | |
Kristina Hachey
DFI | Director of Finance/CFO | - | 27/06/2019 |
Arkady Mandel
CEO | Chief Executive Officer | - | 15/11/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
Randy Bruder
BRD | Director/Board Member | - | 01/01/2008 |
Kristina Hachey
BRD | Director/Board Member | - | 27/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/31/26 A | Option | Director | 3,360 | 0.0011% | ||
| 8/27/26 A | Buy | Chief Executive Officer | 42,000 | 0.0142% | ||
| 8/24/26 A | Option | Chief Financial Officer | 29,000 | 0.0098% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.41% | -5.41% | -5.41% | -5.41% | 40.14M | ||
| -2.79% | -4.38% | +16.90% | +42.75% | 255B | ||
| -3.16% | -5.43% | -0.82% | +4.42% | 160B | ||
| -2.01% | -10.04% | -27.74% | +28.17% | 141B | ||
| -2.35% | -5.32% | -56.54% | -22.92% | 62.31B | ||
| -1.95% | -4.95% | +21.12% | +51.59% | 59.73B | ||
| -1.96% | -1.92% | +3.84% | -14.15% | 53.49B | ||
| -2.83% | -2.06% | +17.45% | +49.48% | 49.43B | ||
| -3.51% | -4.30% | +16.33% | +68.80% | 44.87B | ||
| +1.26% | -11.71% | -1.58% | +48.97% | 42.57B | ||
| Average | -2.52% | -2.97% | -1.64% | +25.17% | 87B | |
| Weighted average by Cap. | -2.40% | -3.60% | -0.30% | +27.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 786K 549K 500K 461K 419K 50.82M 826K 5.61M 2.23M 27.76M 2.06M 2.02M 87.11M | 33.89M 23.66M 21.55M 19.86M 18.06M 2.19B 35.62M 242M 96.06M 1.2B 88.78M 86.91M 3.76B |
| Net income | -4.12M -2.88M -2.62M -2.42M -2.2M -267M -4.33M -29.41M -11.69M -146M -10.8M -10.58M -457M | 6.9M 4.82M 4.39M 4.04M 3.68M 446M 7.25M 49.22M 19.56M 244M 18.08M 17.7M 765M |
| Net Debt | - | - |
Employees
20
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | CA$0.1750 | -5.41% | 62,362 |
| 19/11/26 | CA$0.1850 | +2.78% | 244,001 |
| 18/11/26 | CA$0.1800 | 0.00% | 20,570 |
| 17/11/26 | CA$0.1800 | 0.00% | 61,807 |
| 16/11/26 | CA$0.1800 | -2.70% | 70,233 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1850CAD
Average target price
0.7000CAD
Spread / Average Target
+278.38%
- Stock Market
- Stocks
- TLT Stock
Select your edition
All financial news and data tailored to specific country editions
















